A recent study indicates that people who come off popular slimming jabs like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who end traditional lifestyle regimens.
Published data in a leading health publication shows that while obese people frequently drop substantial amounts of their body weight while using the jabs, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Users buying these drugs must be informed of the risk of fast weight regain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.
Such speed of recovery suggests a return to original mass within about one and a half years.
Weighing Approaches
The research, which examined dozens of studies involving thousands of participants, compared the results of GLP-1 agonists with older methods.
Scientists point out that people who shed pounds through dieting typically have a more gradual creep back—around 0.1 kg a month—once they finish.
Explaining the Fast Rebound
Doctors propose the way of the injections is key to understanding the heightened regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of the hormone levels several times higher than normal could lead to the system to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication leads to appetite is no longer kept in check, making binge eating much more probable."
A Chronic Disease?
Medical guidelines suggest the jabs for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals say that, considering the high risk of relapse, the treatment should be considered life-long.
This view is reinforced by pharmaceutical companies, who state that the findings "underscore the chronic nature of excess weight," similar to managing diseases like hypertension.
Patient Experiences
Users who have come off the jabs explain a intense resurgence of appetite.
"It felt as if a trigger activating and you become ravenous," said a patient.
The struggle is compounded if users have not developed permanent lifestyle or habit changes during therapy.
Widespread Interest
Recent estimates show that a significant number of people in the UK have used weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is greater among females compared to males.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
Finally, clinicians emphasize that while the jabs are effective tools for shedding pounds, they are not a magic cure and lasting health benefits hinges on ongoing behavioural changes.
